LABD vs. XDSQ
LABD (Direxion Daily S&P Biotech Bear 3x Shares) and XDSQ (Innovator US Equity Accelerated ETF) are both Leveraged Equities funds. LABD is passively managed, while XDSQ is actively managed. Over the past 5 years, LABD returned -43.47%/yr vs 9.69%/yr for XDSQ. At a correlation of -0.54, they often move in opposite directions. LABD charges 1.06%/yr vs 0.79%/yr for XDSQ.
Performance
LABD vs. XDSQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LABD achieves a -56.07% return, which is significantly lower than XDSQ's 3.10% return.
LABD
- 1D
- -5.68%
- 1M
- -35.65%
- YTD
- -56.07%
- 6M
- -51.34%
- 1Y
- -86.96%
- 3Y*
- -57.71%
- 5Y*
- -43.47%
- 10Y*
- -59.30%
XDSQ
- 1D
- 0.05%
- 1M
- 0.67%
- YTD
- 3.10%
- 6M
- 1.79%
- 1Y
- 14.96%
- 3Y*
- 14.49%
- 5Y*
- 9.69%
- 10Y*
- —
LABD vs. XDSQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -56.07% | -70.07% | -21.43% | -41.77% | -32.68% | 18.40% |
XDSQ Innovator US Equity Accelerated ETF | 3.10% | 14.22% | 23.12% | 23.00% | -16.78% | 13.28% |
Correlation
The correlation between LABD and XDSQ is -0.46, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.50 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.55 |
Correlation (All Time) Calculated using the full available price history since Apr 1, 2021 | -0.54 |
The correlation between LABD and XDSQ has been stable across timeframes, ranging from -0.55 to -0.46 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LABD vs. XDSQ — Risk / Return Rank
LABD
XDSQ
LABD vs. XDSQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Innovator US Equity Accelerated ETF (XDSQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LABD | XDSQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.54 | ||
| Sortino ratioReturn per unit of downside risk | -4.70 | ||
| Omega ratioGain probability vs. loss probability | 0.70 | 1.30 | -0.60 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 1.57 | -2.56 |
| Martin ratioReturn relative to average drawdown | -1.37 | 7.47 | -8.83 |
Loading charts...
Drawdowns
LABD vs. XDSQ - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than XDSQ's maximum drawdown of -26.06%. Use the drawdown chart below to compare losses from any high point for LABD and XDSQ.
Loading charts...
Drawdown Indicators
| LABD | XDSQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -26.06% | -73.93% |
Max Drawdown (1Y)Largest decline over 1 year | -87.41% | -9.60% | -77.81% |
Max Drawdown (3Y)Largest decline over 3 years | -96.58% | -19.15% | -77.43% |
Max Drawdown (5Y)Largest decline over 5 years | -98.72% | -26.06% | -72.66% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | — | — |
Current DrawdownCurrent decline from peak | -99.99% | 0.00% | -99.99% |
Average DrawdownAverage peak-to-trough decline | -90.99% | -4.91% | -86.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.63% | 2.01% | +61.62% |
Volatility
LABD vs. XDSQ - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 29.86% compared to Innovator US Equity Accelerated ETF (XDSQ) at 0.59%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than XDSQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LABD | XDSQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.86% | 0.59% | +29.27% |
Volatility (6M)Calculated over the trailing 6-month period | 64.89% | 8.00% | +56.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.92% | 10.50% | +68.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.65% | 15.28% | +81.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.96% | 15.02% | +80.94% |
LABD vs. XDSQ - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than XDSQ's 0.79% expense ratio.
Dividends
LABD vs. XDSQ - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 7.15%, while XDSQ has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 7.15% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% |
XDSQ Innovator US Equity Accelerated ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
LABD and XDSQ have a correlation of -0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (29.86%) compared to XDSQ (0.59%). In terms of maximum drawdown, LABD dropped -99.99% vs XDSQ's -26.06%.
On 5-year performance, XDSQ leads with 9.69% vs -43.47% for LABD. On fees, XDSQ is cheaper at 0.79% per year. On volatility, XDSQ has been the lower-risk option at 0.59%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, XDSQ has performed better with a 9.69% return vs -43.47%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XDSQ is cheaper with a 0.79% expense ratio, compared with 1.06% for LABD.
LABD has the higher dividend yield at 7.15%, compared with 0.00% for XDSQ.
They also come from different issuers: Direxion and Innovator. Their fees differ too: 1.06% for LABD and 0.79% for XDSQ.
XDSQ currently has the higher Sharpe Ratio (1.43 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LABD and XDSQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer